0001193805-24-000065.txt : 20240119 0001193805-24-000065.hdr.sgml : 20240119 20240119160538 ACCESSION NUMBER: 0001193805-24-000065 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 EFFECTIVENESS DATE: 20240119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNIC, INC. CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562358443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-502974 FILM NUMBER: 24545604 BUSINESS ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 BUSINESS PHONE: (332) 255-9818 MAIL ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: VITAL THERAPIES INC DATE OF NAME CHANGE: 20040219 D 1 primary_doc.xml X0708 D LIVE 0001280776 IMMUNIC, INC. 1200 AVENUE OF THE AMERICAS, SUITE 200 NEW YORK X1 UNITED STATES 10036 (332) 255-9818 DELAWARE Vital Therapies, Inc. VITAL THERAPIES INC Corporation true Daniel Vitt 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Executive Officer Director Duane Nash 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Director Executive chairman of board of directors Tamar Howson 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Director Barclay Phillips 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Director Jorg Neermann 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Director Richard Rudick 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Director Andreas Muehler 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Executive Officer Patrick Walsh 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Executive Officer Maria Tornsen 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Director Hella Kohlhof 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Executive Officer Chief Scientific Officer Glenn Whaley 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Executive Officer Inderpal Singh 1200 Avenue of the Americas, Suite 200 New York NY NEW YORK 10036 Executive Officer General Counsel Biotechnology No Revenues 06b false 2024-01-04 true true true true false 0 None None Leerink Partners LLC 39011 1301 AVENUE OF THE AMERICAS 12TH FLOOR NEW YORK NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NY NEW YORK TX TEXAS false None None Ladenburg Thalmann & Co. Inc. 505 640 5TH AVENUE, 4TH FLOOR NEW YORK NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NY NEW YORK TX TEXAS false 240000000 80000016 159999984 Offering to be sold in 3 tranches of $80,000,000 each, subject to specified conditions. Third tranche permits funding on a "cashless" or net exercise basis. false 19 4800000 0 The sales commissions amount exclusively pertains to the total amount sold in the first tranche of this offering. 0 false IMMUNIC, INC. /s/ Glenn Whaley Glenn Whaley Chief Financial Officer 2024-01-19